Form 4 holding
Chief Global Commercialization Officer
Revolution Medicines, Inc.
- Security class
- Common Stock
- Shares / value
- 39,765
- Estimated value
- $7,953,000
- Report date
- 09 Nov 2026
- Price
- $200.00
- Ownership
- Direct